PDA
PDA
$ 44
A synthetic 15-amino-acid peptide (pentadecapeptide) with an arginine modification — essentially a next-generation BPC-157 variant. The arginine substitution is intended to improve stability, bioavailability, and potency compared to original BPC-157. Stimulates collagen synthesis, promotes angiogenesis, reduces inflammation, and accelerates healing of tendons, ligaments, muscles, and gut tissue. Considered an upgrade to BPC-157 by many practitioners.
Benefits
✓ Improved collagen synthesis and tissue regeneration
✓ Potent anti-inflammatory effects
✓ Gut healing and protection
✓ Wound healing promotion
✓ Potentially more stable and bioavailable than BPC-157
✓ Muscle repair and recovery
✓ Angiogenesis (new blood vessel formation) at injury sites
Side Effects
• Headache
• Dizziness
• Nausea
• Fatigue
• Flu-like symptoms
• Very limited human clinical trial data — newer compound than BPC-157
• No established FDA-approved dosing
Note
PDA
$ 44
A synthetic 15-amino-acid peptide (pentadecapeptide) with an arginine modification — essentially a next-generation BPC-157 variant. The arginine substitution is intended to improve stability, bioavailability, and potency compared to original BPC-157. Stimulates collagen synthesis, promotes angiogenesis, reduces inflammation, and accelerates healing of tendons, ligaments, muscles, and gut tissue. Considered an upgrade to BPC-157 by many practitioners.
✓ Improved collagen synthesis and tissue regeneration
✓ Potent anti-inflammatory effects
✓ Gut healing and protection
✓ Wound healing promotion
✓ Potentially more stable and bioavailable than BPC-157
✓ Muscle repair and recovery
✓ Angiogenesis (new blood vessel formation) at injury sites
Related Products
